All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.

Moderators

Matthew Hartwig, MD
Disclosure(s): Intuitive Surgical Inc.: Speaker (Ongoing)

Errol Bush, MD

Presentations

1. Endobronchial Valve Therapy vs. Lung Volume Reduction Surgery in the United States
   J.W. Awori Hayanga, MD, MPH, FACS
    
2. The United States Experience with Combined Lung and Liver Transplantation
   Liam R. Kugler, BS
    
3. The Impact of Various Ex Vivo Lung Perfusion Strategies on Transplantation Outcomes: A Comprehensive Analysis of Data from the United Network for Organ Sharing
   Amer Alzahrani, MD, RRT
    
4. The Survival Paradox in Sarcoidosis Patients Undergoing Lung transplantation: Overview of the Lung Allocation Score Era
   Theodore M. Lin, MD
    
5. The Impact of Kidney Transplantation on Survival Outcomes for Lung Transplantation
   Lynette A. Lester, MD
    
6. Gender Disparity in Waitlist Outcomes of Lung Transplantation in the Composite Allocation Score System
   Peter D. Cho, BS
    
7. Lung Transplantation with Ex Vivo Lung Perfusion: A United Network for Organ Sharing Database Analysis
   Matthew P. Weber, MD
    
8. Robotics in Lung Transplantation
   Stephanie H. Chang, MD
   Disclosure(s): Astrazeneca: Advisory Board (Terminated, October 1, 2024); AtriCure: Speaker (Ongoing)
    
9. Ex Vivo Lung Perfusion in 2025: What's Next?
   Gabriel Loor, MD
   Disclosure(s): Abiomed / Breethe: Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Atricure: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Organvive: Owner/Co-Owner Founder/Co-Founder (Ongoing); TransMedics: Advisory Board (Ongoing), Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)
    
10. Discussion